Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
Condition(s):Pregnancy Related; Atopic DermatitisLast Updated:March 5, 2024Recruiting